---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-015295"
form_type: "8-K"
ticker: "ATYR"
cik: "0001339970"
company_name: "aTYR PHARMA INC"
filed_at: "2022-04-22T23:59:59+00:00"
generated_at: "2026-06-26T05:18:50.740391+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# aTyr Pharma enters into $65M at-the-market offering agreement with Jefferies, terminates prior JonesTrading ATM

## Summary
- aTyr Pharma entered into Open Market Sale Agreement with Jefferies LLC to sell up to $65M of common stock at market prices on Nasdaq.
- The agreement includes a 3.0% commission to Jefferies on gross proceeds from each sale of shares.
- Company terminated the prior Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC dated March 23, 2021.
- Prior agreement allowed up to $25M in common stock sales through JonesTrading as sales agent.
- Shares will be sold under existing shelf registration statement (File No. 333-250095) effective November 23, 2020.

## SEC filing metadata
- accession: 0001564590-22-015295
- form_type: 8-K
- ticker: ATYR
- cik: 0001339970
- company_name: aTYR PHARMA INC
- filed_at: 2022-04-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339970/000156459022015295/0001564590-22-015295-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339970/000156459022015295/life-8k_20220422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-015295
- JSON: https://secwatch.observer/filing/0001564590-22-015295.json
- Plain text: https://secwatch.observer/filing/0001564590-22-015295.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.